Optimized biodegradable polymeric reservoir‐mediated local and sustained co‐delivery of dendritic cells and oncolytic adenovirus co‐expressing IL‐12 and GM‐CSF for cancer immunotherapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-08-10

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1016/j.jconrel.2017.03.028PMID 28336378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic Cell–Based Immunotherapy: State of the Art and Beyond

  2016cited by this paper
• Enzyme-catalyzed in situ forming gelatin hydrogels as bioactive wound dressings: effects of fibroblast delivery on wound healing efficacy.

  2014cited by this paper
• Clinical use of dendritic cells for cancer therapy.

  2014cited by this paper
• In Situ Crosslinkable Gelatin Hydrogels for Vasculogenic Induction and Delivery of Mesenchymal Stem Cells

  2014cited by this paper
• Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-γ- and TNF-α-Co-Producing T Cell-Mediated Antitumor Immunity

  2013cited by this paper
• Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy

  2013cited by this paper
• Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients

  2013cited by this paper
• Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma

  2012cited by this paper
• A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma.

  2011cited by this paper
• Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα

  2011cited by this paper
• Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF

  2011influential reference
• Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF

  2011influential reference
• Antitumor effects of combined granulocyte macrophage colony stimulating factor and macrophage inflammatory protein‐3 alpha plasmid DNA

  2010cited by this paper
• Reciprocal activating interaction between 6‐sulfo LacNAc+ dendritic cells and NK cells

  2009cited by this paper
• Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL

  2009cited by this paper
• Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.

  2009cited by this paper
• Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy.

  2008cited by this paper
• Cytokine gene transfer for cancer therapy.

  2007cited by this paper
• Optimizing dendritic cell-based immunotherapy for cancer

  2007cited by this paper
• DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors

  2007cited by this paper
• Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.

  2006cited by this paper
• Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model

  2006cited by this paper
• Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.

  2006cited by this paper
• Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect

  2006cited by this paper
• Oncolytic virotherapy for cancer treatment: challenges and solutions

  2005cited by this paper
• Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

  2005cited by this paper
• Gene therapy of cancer based on interleukin 12.

  2005cited by this paper
• Dendritic cells as therapeutic vaccines against cancer

  2005cited by this paper
• Cytokines in cancer pathogenesis and cancer therapy

  2004cited by this paper
• Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo

  2004cited by this paper
• Dendritic cells: a journey from laboratory to clinic

  2004cited by this paper
• Molecular mechanisms regulating Th1 immune responses.

  2003cited by this paper
• Cellular Mechanism of Thymic Involution

  2003cited by this paper
• Cytokine- and chemokine-based gene therapy for cancer.

  2003cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation.

  1998cited by this paper
• Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.

  1997cited by this paper
• A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma.

  1997cited by this paper
• Gene Therapy for Metastatic Brain Tumors by Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Tumor Cells

  1997cited by this paper
• Role of Alveolar Macrophages in Rapid Elimination of Adenovirus Vectors Administered to the Epithelial Surface of the Respiratory Tract

  1997cited by this paper
• Follow‐up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

  1997cited by this paper
• Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration

  1997cited by this paper
• Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production

  1997cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• Cancer Trial of Interleukin-12 Halted

  1995cited by this paper
• Immune Response

  1969cited by this paper

• Hydrogel-based delivery of cytokines in cancer immunotherapy: Latest evidence and therapeutic outcomes.

  2026cites this paper
• Hydrogel-Based Vaccines: A Promising Approach for Cancer Immunotherapy

  2025cites this paper
• Beyond the tumor microenvironment: Orchestrating systemic T-cell response for next-generation cancer immunotherapy (Review)

  2025cites this paper
• Recent advances in oncolytic virus combined immunotherapy in tumor treatment

  2025cites this paper
• Recent Advances in Polysaccharide-Based Hydrogels for Tumor Immunotherapy

  2025cites this paper
• IL-12 and GM-CSF engineered dendritic cells enhance the enrichment and selection of tumor-reactive T cells for cancer immunotherapy

  2025cites this paper
• Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations.

  2024cites this paper
• Exploration of the Delivery of Oncolytic Newcastle Disease Virus by Gelatin Methacryloyl Microneedles

  2024cites this paper
• Engineered Bio‐Based Hydrogels for Cancer Immunotherapy

  2024cites this paper
• Development of immune cell delivery system using biodegradable injectable polymers for cancer immunotherapy.

  2024cites this paper
• Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy

  2024cites this paper
• Novel combination therapy using recombinant oncolytic adenovirus silk hydrogel and PD-L1 inhibitor for bladder cancer treatment

  2024cites this paper
• Biomaterial‐Based Therapeutic Delivery of Immune Cells

  2024cites this paper
• Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy

  2024cites this paper
• Application of injectable hydrogels in cancer immunotherapy

  2023cites this paper
• Endogenus chondrocytes immobilized by G-CSF in nanoporous gels enable repair of critical-size osteochondral defects

  2023cites this paper
• Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?

  2023cites this paper
• Drug delivery methods for cancer immunotherapy

  2023cites this paper
• Nanomedicine-based adjuvant therapy: a promising solution for lung cancer

  2023cites this paper
• Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model

  2023cites this paper
• Emerging biomaterials for tumor immunotherapy

  2023cites this paper
• Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment

  2023cites this paper
• A diffusive cancer model with virotherapy: Studying the immune response and its analytical simulation

  2023cites this paper
• Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design.

  2023cites this paper
• Improved Targeting of Therapeutics by Nanocarrier-Based Delivery in Cancer Immunotherapy and Their Future Perspectives

  2023cites this paper
• Biomaterials for enhanced immunotherapy

  2022cites this paper
• Local immunotherapy of cancer and metastasis

  2022cites this paper
• Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment

  2022cites this paper
• Polymeric Systems for Cancer Immunotherapy: A Review

  2022cites this paper
• Hydrogel-based co-delivery of CIK cells and oncolytic adenovirus armed with IL12 and IL15 for cancer immunotherapy.

  2022cites this paper
• Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives.

  2022cites this paper
• Approaches to generating virtual patient cohorts with applications in oncology

  2022cites this paper
• Metabolic Reprogramming by Dual-targeting Biomimetic Nanoparticles for Enhanced Tumor Chemo-Immunotherapy.

  2022cites this paper
• Title: Localized Nano-mediated Interleukin-12 Gene Therapy: Promising candidate for Cancer Immunotherapeutics.

  2022cites this paper
• Nonviral vector system for cancer immunogene therapy

  2022cites this paper
• Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements

  2022cites this paper
• Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy

  2022cites this paper
• Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review

  2022cites this paper
• Injectable and photocurable CAR-T cell formulation enhances the anti-tumor activity to melanoma in mice.

  2022cites this paper
• Intelligent nanotherapeutic strategies for the delivery of CRISPR system

  2022cites this paper
• Potent and Targeted Sindbis Virus Platform for Immunotherapy of Ovarian Cancer

  2022cites this paper
• Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase A silencing for enhanced cancer immunochemotherapy.

  2021cites this paper
• Effect of hydroxychloroquine sulfate on the gelation behavior, water mobility and structure of gelatin

  2021cites this paper
• Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment

  2021cites this paper
• Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective.

  2021cites this paper
• Polymer-based hydrogels with local drug release for cancer immunotherapy.

  2021cites this paper
• Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements

  2021cites this paper
• Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming

  2021cites this paper
• Doxorubicin/CpG self-assembled nanoparticles prodrug and dendritic cells co-laden hydrogel for cancer chemo-assisted immunotherapy

  2021cites this paper
• Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines

  2021cites this paper
• Hydrogel/nanoadjuvant-mediated Combined Cell Vaccines for Cancer Immunotherapy.

  2021cites this paper
• Advances in engineering local drug delivery systems for cancer immunotherapy.

  2020cites this paper
• Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model.

  2020cites this paper
• Improving safety of cancer immunotherapy via delivery technology.

  2020cites this paper
• Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines

  2020cites this paper
• Designer nanocarriers for navigating the systemic delivery of oncolytic viruses.

  2020cites this paper
• Enhancing Oncolytic Virotherapy: Observations from a Voronoi Cell-Based Model.

  2020cites this paper
• Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy

  2020cites this paper
• Engineered biomaterials for cancer immunotherapy

  2020cites this paper
• Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells

  2020influential citation
• Biomaterial scaffold-based local drug delivery systems for cancer immunotherapy.

  2020cites this paper
• Recent advances in gelatin-based therapeutics

  2019cites this paper
• Self-Assembling Peptides as Building Blocks of Functional Materials for Biomedical Applications

  2019cites this paper
• Engineering Protein Delivery Depots for Cancer Immunotherapy.

  2019cites this paper
• Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.

  2019cites this paper
• Injectable Hydrogels for Cancer Therapy over the Last Decade

  2019cites this paper
• Overcoming the limitations of locally administered oncolytic virotherapy

  2019cites this paper
• Engineered horseradish peroxidase-catalyzed hydrogels with high tissue adhesiveness for biomedical applications

  2019cites this paper
• Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy.

  2019cites this paper
• Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches

  2018cites this paper
• 19F-MRI to Monitor Therapeutic Cell Migration and Distribution

  2018cites this paper
• Hydrogels as Emerging Materials for Translational Biomedicine

  2018cites this paper
• DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment

  2017cites this paper